We present an insight of the effects of combination therapy with neurotrophin-3 and neural stem cell on functional recovery after spinal cord injury (SCI). Total RNA was extracted from neural stem cell line C17.2 and reversed transcribed into cDNA. Neurotrophin-3 (NT-3) gene was amplified by PCR and subcloned into plasmid to construct an expression vector pNT-3. A positive clone containing pNT-3, named SHN2, was obtained and used for transplantation. Thirty adult mice received mechanical injury at the T8 vertebra level. Cell survival, NT-3 gene expression, and functional recovery were observed through X-Gal staining, RT-PCR, and open field locomotion, respectively. The results show that NT-3 gene comprising 777 bp nucleotides was cloned and a more than twofold expression was detected when transfected into neural stem cell line C17.2. Quantitative analysis of cellular density revealed a significant increase in SHN2 compared to the control cells (p < 0.01). Thirty days after transplantation, SHN2 showed significant increase near the lesion site. Furthermore, the functional recovery indicated an active effect by detecting Basso-Beattie-Bresnahan (BBB) locomotor rating scale (p < 0.01). In conclusion, combined treatment of neural stem cells and NT-3 gene can facilitate functional recovery. It offers an effective approach to treat SCI.
INTRODUCTION
. Findings indicated that immune cells were able to produce a variety of neurotrophic factor that promote neuronal survival and may also mediate anti-inflamma-The natural capacity of the central nervous system (CNS) to recover from injury is limited (12). Thus, most tory effects (5) . Although initial observations suggested that astrocytic gliosis was linked to failure of axonal re-research of spinal cord injury (SCI) focuses on promoting cell growth and reducing neuronal degeneration. In generation in the adult mammalian CNS, further in vitro and in vivo experiments now provide evidence that order to improve SCI, neural stem cells were reported to establish the functional remyelination following trans-astrocytes are essential for growth support and that macrophages can reverse the failure of CNS growth. One of plantation (21) . Genetically modified neural progenitor or stem cells have been shown to ameliorate experimen-the better characterized therapies for spinal cord injury (SCI) is intraspinal transplantation of fibroblasts modi-tal SCI, providing neurotrophic support or replace missing neural cells.
fied to secrete neurotrophins. Primary skin fibroblasts, genetically modified to produce neurotrophin-3 (NT-3), Neural stem cell line C17.2 is a well-characterized line of cells that is immortalized with a recombinant ret-could promote corticospinal tract regeneration and locomotion recovery following transplantation (7,11). There-rovirus vector containing the v-myc oncogene. This cell line underwent continual mitotic cycling in vitro but fore, the preferred therapy for chronic injury may need to provide factors that will enable neurons to withstand showed no continued proliferation in situ (10). Furthermore, it has been reported that grafting these cells to the a second axotomy, as well as factors that will elicit regeneration from surviving neurons. Primary fibroblasts nervous system could correct various abnormalities in models of abnormal CNS development or injury (14,17, modified to express NT-3 supported corticospinal tract regeneration and partial recovery of hind limb function 22,23).
Recently, gene therapy has been used to promote ax-after dorsal thoracic hemisection. However, to our knowledge, there is little informa-onal regeneration after brain injury and SCI (4,16,19, tion available in the literature about combined treatment followed by 30 cycles of 95°C for 1 min, 60°C for 1 min, and 72°C for 1 min. For NT-3 amplification, after of neural stem cells and NT-3 gene after spinal cord injury in mice. We present the results of combined ther-denaturing at 95°C for 3 min, a series of 30 cycles was performed at 95°C for 1 min, 53°C for 1 min, and 72°C apy at the cellular and animal behavior level that may be of importance in understanding the theoretical mech-for 1 min by using the forward and reverse primers mentioned above. To determine optimal experimental condi-anism and clinic application in injury recovery.
tions for relative quantification of transcripts, we prelim-
MATERIALS AND METHODS
inarily tested RT-PCR at several cycle numbers (30 Cell Culture cycles) with variable cDNA concentrations (0-0.2 µg cDNA). Using two sets of independently prepared The C17.2 cell line was kindly donated by Prof.
cDNA samples, RT-PCR was performed in triplicate for E. Y. Snyder. It was isolated initially from neonatal each (8). mouse cerebellum. It contains a lacZ gene and a neo resistance gene. Cells were grown at 37°C at standard Spinal Cord Injury humidified atmosphere and 5% CO 2 in high-glucose
Adult female mice (n = 30, weight 40-45 g, Kun DMEM containing 10% fetal bovine serum (Sigma), 5%
Ming) were anesthetized with chloral hydrate (40 mg/ horse serum (Gibco), 1 mM glutamine, and tri-antibiotkg). A spinal cord dorsal column lesion was made after ics (Invitrogen). For normal maintenance, cells were the anesthetized mouse received a partial vertebral lepassaged once per week at density (1:5) and refed with sion to expose the dorsal surface of the midthoracic spifresh medium twice weekly (9). nal cord (T8 vertebral level) (1). The knife was slowly Cloning of NT-3 Gene and Construction lowered onto the exposed spinal cord with a touch force of Expressed Vector amplitude of 30 s, and spinal tissue was compressed against the knife until all visible white matter was tran-Total RNA was extracted from the neural stem cell sected. line C17.2 and reverse transcribed into cDNA by using the Trizol RNA Isolation Kit (Shanghai Sango) accord-
Transplant of Neural Stem Cells ing to the manufacturer's instructions. NT-3 gene was
The mice with T8 lesions were anesthetized with an amplified by PCR using the forward primer GTACCAT IP injection of chloral hydrate (40 mg/kg). Animals GTCCATCTTGTTTTATG and the reverse primer AGA were grafted with C17.2 (n = 10) and SHN2 (n = 10) TGGTACCTCATGTTCCAATT. The PCR product was cells into the spinal cord at the 9th day after SCI. Apdigested and inserted into the plasmid p-EGFP-C1 to proximately 2 × 10 5 C17.2 cells and SHN2 cells were construct an expression plasmid pNT-3. After transforminjected into the medial septum with a dram syringe held ing C17.2 cells for 3 days, the positive clone of the exin the stereotaxic frame. The cells were injected over 5 pressing NT-3 gene, named SHN2, was screened via flumin and the needle was left in place for an additional 5 orescence and applied to the transplant. min before withdrawal. Control mice (n = 10) received Observation of Neural Stem Cell Proliferation In Vitro an equal volume (5 µl) of normal saline. C17.2 and SHN2 were tested for their proliferation Detection of the Transplanted Cells potential in vitro. Briefly, 1 × 10 5 cells/well were seeded Transplanted cells are identified by testing β-galacin 24-well plates and cultured for up to 1 week. The tosidase activity using X-Gal staining. The transplanted number of transferred cells was then quantified in three mice were killed on day 28 after transplantation, and randomly selected fields at 200× under a fluorescence perfused transcardially with saline followed by 4.0% microscope. paraformaldehyde in 0.1 M phosphate buffer containing Reverse Transcriptase Polymerase 2.0 mM MgCl 2 and 1.25 mM ethylenebis (oxyethylene-Chain Reaction (RT-PCR) nitrilo) tetra acetic acid (EGTA) to inhibit endogenous β-galactosidase activity. Cultured C17.2 cells were After the cells were replenished with PBS, total RNA was extracted with RNeasy RNA extraction kit (Sangon) rinsed with PBS and then fixed for 5 min with 2.0% paraformaldehyde in phosphate buffer. The spinal cord followed by DNase I treatment to remove genomic DNA contamination. Total RNA (2 µg) was reverse-tran-was removed by knife at the 7-9 level. Specimens were then frozen in OCT compound and serially sectioned on scribed with oligo(dT) primer and RNase reverse transcriptase for 1 h at 42°C (Gibco BRL). After treatment a freezing microtome at 20 µm for spinal cord tissue. The slices were incubated in a solution of 2.0 mM with RNase H, the synthesized cDNA was subjected to PCR amplification. β-Actin amplification was carried MgCl 2 , 5.0 mM potassium ferrocyanide, and 5.0 mM potassium ferricyanide in 0.01 M phosphate-buffered sa-out with an initial denaturation step at 95°C for 3 min, line (PBS). The X-Gal was used at a concentration of pEGFP-C1 at the KpnI site of expression vector pNT-3EGFP-C1 ( Fig. 1B ). 1.0 mg/ml in the reaction solution (6).
Behavioral Assessment Overexpression of NT-3 Enhances Neurite Outgrowth and Cell Proliferation In Vitro
The recovery of gross overground locomotion was evaluated once per week by the Basso-Beattie-Bresna-In order to examine the effects of NT-3 on neurite han (BBB) locomotor rating scale (2) . In addition, asoutgrowth in vitro, the cellular differentiation status was pects of fine hind limb and trunk control during locomocompared between cell line C17.2 and SHN2. Following tion were described as detailed previously (13). The 3 days in culture, C17.2 cells demonstrated a limited score consisted of 21 different criteria of the hind limb number in neuritis ( Fig. 2A ). However, SHN2 resulted movement and eventually evaluated after 4 weeks postin a marked increase in neurite outgrowth (Fig. 2B ). transplantation (3) .
Quantitative analysis of SHN2 cells revealed a signifi-Comparisons between the experiment and the control cant increase in the cellular density (p < 0.01) compared group were performed using one-way ANOVA with to C17.2 cells (Fig. 2C) . These results indicate that NT-Bonferroni's posttest at each time point postinjury.
3 promotes axonal outgrowth and cell increment. Con-Group differences for injury biomechanical parameters, comitantly, analysis of mRNA by RT-PCR further idenfoot misses/s on grid walking, base of support and toe tified that NT-3 expressional level in SHN2 cell was drags from footprint analysis, correlation analyses besignificantly increased by approximately twofold comtween open field locomotion (final BBB scores at 30 pared to that of C17.2 alone (Fig. 2B ). days posttransplantation), and biomechanical parameters Observation of Inanition in Spinal Cord Injury or histological outcomes were performed using Spearman rank order correlation. Null hypotheses were re-Four weeks after injury transplants were injected with jected at the p < 0.05 level. All analyses were done on C17.2 and SHN2. The host spinal cord tissues were obprograms available on GraphPad Prism 3 (GraphPad served. Analysis of histological sections by Image-Pro Software, Inc., San Diego, CA).
Plus (IPP) software showed existence of an obvious lumen (2783 µm 2 ) in injured animals at the site of injec-RESULTS tion C17.2 (Fig. 3A) . Surprisingly, little lumen (700
Cloning of NT-3 Gene and Construction
µm 2 ) was found in the spinal cord of animals that reof Expression Vector ceived SHN2 transplants (Fig. 3B ). The NT-3 gene was cloned from C17. 2 
neural stem
Detection of Grafted Region cell cDNA by using PCR (Fig. 1A) . A full-length NT-3 gene comprises a 777-base pair nucleotide fragment At sacrifice, all grafted regions appeared translucent and were closely adherent to the host cord. The region encoding an open reading frame of 258 amino acids. Sequencing indicated that the cloned fragment is accu-of the spinal cord containing the graft was sectioned parasagittally to determine the length of the lesion/trans-rate (data not shown). NT-3 gene was then inserted into plant. After 4 weeks posttransplantation, graft cells were played immediate but temporary hind limb paralysis, and all animals displayed some extent of locomotor tested by X-Gal staining. The results indicated by Image-Pro Plus showed that only 24 C17.2 cells main-recovery. To determine if the presence of NSC graft would produce behavioral effects resembling those seen tained survival (Fig. 4A) , whereas a large amount of SHN2 cells (75 cells) existed in the injury site (Fig. 4B) .
with exogenous neurotrophic factor treatment in injured mice, all animals in this study were tested at 5-day inter-These results indicate that the SHN2 cell line is more permissive towards livability than the C17.2 cell line.
vals for the presence of spontaneous hind limb air stepping by suspending the animal with thoracic support Functional Effects of the Cell Grafts only. Transplanted mice with SHN2 and C17.2 showed active coordinated hind limb stepping at the third week To assess the functional effects of intraspinal neural stem cell (NSC) transplantation, hind limb use during after SCI, whereas mice without transplanting either NT-3 or C17.2 exhibited uncoordinated hind limb spasms dur-voluntary overground locomotion was analyzed using the BBB locomotor rating scale (Fig. 5 ). Following SCI ing the same time (p < 0.01). However, there was no obvious difference between SHN2 and C17.2 until the or SCI plus C17.2 NSC/SHN2 transplantation, mice disday 30.
DISCUSSION
In this study, the effects of a combinatorial treatment of NT-3 gene and neural stem cells method were investigated. When NT-3 was expressed in neural stem cells, it would promote cellular survival and proliferation. Transplant experiments demonstrated that both C17.2 and SHN2 could obviously enhance functional recovery after SCI. However, through the BBB scores method, we did not find a distinct difference regarding functional recovery between SHN2 and C17.2 until day 30 after SCI. At the cellular level, histological sections revealed that NSCs could enhance the density after SCI. X-Gal staining indicated graft cellular survival at the injury site at the fourth week after SCI. These observations impli- 
